Otros idiomas Viking Therapeutics, Inc.

Acciones

VKTX

US92686J1060

Mercado cerrado - Nasdaq Otros sitios de cotización 21:59:48 04/06/2024			Pre-apertura 13:04:20
56,23 ^USD	-9,70 %		56	-0,41 %

04/06	Actualización del sector: Las acciones de atención médica se mantuvieron estables antes de la campana del martes	MT
04/06	Viking Therapeutics informa de resultados "positivos" a 52 semanas para su fármaco contra la EHNA; las acciones suben antes de Bell	MT

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Health Care Climbs on Defensive Bias - Health Care Roundup	04/06
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	04/06
Viking Therapeutics Reports 'Positive' 52-Week Results for NASH Drug; Shares Rise Pre-Bell	04/06
Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)	04/06
Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2B Voyage Study of Vk2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis	04/06
Viking Therapeutics to Participate at Upcoming Investor Conferences	30/05
North American Morning Briefing : The "Everything -2-	17/05
Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing	06/05
Wall St set to open sharply higher on soft jobs data	03/05
Amgen shares jump after teasing weight-loss drug data, rivals slip	03/05
Viking Therapeutics Insider Sold Shares Worth $22,136,474, According to a Recent SEC Filing	03/05
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	25/04
Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours	24/04
Viking Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
6 Stocks Positioned to Soar as Investors Focus on MASH	22/04
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024	17/04
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup	12/04
Health Care Down on Flight From Risk -- Health Care Roundup	02/04
Health Care Down as Obesity-Drug Optimism Fades -- Health Care Roundup	01/04
Health Care Climbs on Weight-Loss Drug Excitement -- Health Care Roundup	26/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Viking Therapeutics, Inc.

Acciones

VKTX

US92686J1060

Otros idiomas

Filtros